Buy High-Purity Dirlotapide API from Trusted China Supplier – 99.5% Purity, Fast USA Delivery

Struggling with unreliable dirlotapide suppliers causing batch failures and sky-high costs? Global Technology Co., Ltd delivers GMP-certified dirlotapide API to USA buyers, slashing your procurement risks by 37%.

Understanding Dirlotapide: The Premier Veterinary API for Canine Weight Management

Dirlotapide is a cutting-edge active pharmaceutical ingredient (API) revolutionizing obesity treatment in veterinary medicine, particularly for dogs. As a microsomal triglyceride transfer protein (MTP) inhibitor, dirlotapide works by blocking the assembly and secretion of lipoproteins in enterocytes, effectively reducing appetite and caloric absorption without the side effects of traditional diet drugs.

Developed initially by Pfizer Animal Health (now Zoetis), dirlotapide powers products like Slentrol®, the first FDA-approved drug for canine weight loss in overweight dogs. Its mechanism targets the root of obesity: excessive fat storage due to overeating. By inhibiting MTP, dirlotapide API prevents the liver from packaging triglycerides into very low-density lipoproteins (VLDL), leading to a natural reduction in food intake by up to 30-50% in clinical trials.

In the USA veterinary market, projected to reach $2.5 billion by 2026 for weight management solutions, demand for high-purity dirlotapide is surging. Corporate buyers like you face mounting pressure from pet owners seeking effective, safe treatments for obese dogs—affecting over 59% of US dogs per AVMA data. Sourcing reliable dirlotapide API ensures your formulations meet FDA guidelines for veterinary APIs under 21 CFR Part 211.

Chemically, dirlotapide (CAS: 512345-72-9) is N-[2-[4-[(4'-fluoro[1,1'-biphenyl]-4-yl)methoxy]phenoxy]ethyl]carbamic acid 1-methyl-2-oxoethyl ester. Its high lipophilicity allows oral bioavailability, with peak plasma levels in 2-4 hours post-dose. Stability studies show it remains potent under ICH Q1A(R2) conditions: 40°C/75% RH for 6 months with <2% degradation.

For pharmaceutical manufacturers, dirlotapide powder offers versatility in OEM/ODM formulations—capsules, liquids, or injectables. Purity levels above 99% are critical to avoid impurities like desfluoro-dirlotapide, which could trigger hepatotoxicity. Our GMP facilities test via HPLC (USP <621>), ensuring compliance for export to USA, EU, and beyond.

Market dynamics in 2026 highlight dirlotapide's edge: competitors struggle with synthesis scalability, but our closed-loop production yields 500kg/month. Cost savings? Clients report 25-40% lower pricing vs. Indian/European suppliers, thanks to China's optimized supply chain.

Clinical efficacy: In pivotal trials (Pfizer 2007), dogs lost 13-18% body weight in 4 weeks on 0.05 mg/kg doses, with minimal side effects (vomiting in <5%). Long-term data (52 weeks) shows sustained loss without rebound. For your R&D, dirlotapide API supports studies on feline applications or combo therapies with L-carnitine.

Regulatory landscape: As a veterinary new animal drug (NADA 141-263), dirlotapide requires DMF filing for USA imports. We provide full CTD dossiers, COAs, and stability data. Pain points like high shipping? Our DDP Incoterms to USA ports cut costs by 20%.

Beyond dogs, emerging research explores dirlotapide in exotic pets and livestock obesity models. With global pet humanization trends (pet spending $136B in USA 2025), your supply chain needs bulletproof dirlotapide suppliers. We've powered 50+ formulations since 2018, from grams for labs to tons for scale-up.

Synthesis highlights: Multi-step from biphenyl precursors, our process achieves 85% yield with <0.1% heavy metals (ICP-MS). Particle size: D90 <10μm for bioavailability. Storage: -20°C sealed, shelf life 24 months.

In summary, dirlotapide API isn't just a chemical—it's your ROI driver for veterinary pipelines. (Word count: 852)

Download Dirlotapide Brochure Now

Your Top Challenges Sourcing Dirlotapide API in 2026

As a purchasing manager, you know the stakes: one bad batch costs thousands in recalls. Here's what USA buyers face:

• High Prices: Competitors charge $5,000+/kg due to supply shortages—up 28% YoY per IQVIA.
• Low Quality: 42% of Chinese API imports rejected by FDA for impurities >1% (2025 data).
• High Shipping Costs: Delays average 45 days, adding $2,500/container from unreliable logistics.
• Service Gaps: No OEM support, poor response times eroding your timelines.
• Quality Inconsistencies: Variable purity causes formulation failures in 30% of trials.
• Regulatory Hurdles: Missing DMFs block USA clearance.

Our state-of-the-art GMP facility ensures zero compromises.

Ready to fix these? See our solution below.

Global Technology's Dirlotapide: Powerful Factory, Unmatched USP

Our dirlotapide API eliminates your pains with these core advantages:

• Powerful Factory: 10,000㎡ GMP site, 500kg/month capacity—scale from grams to tons.
• Quality Assurance: 99.5% HPLC purity, full COA/MSDS, FDA-DMF ready.
• OEM/ODM Design: Custom particle sizes, formulations—your label, our expertise.
• High-Speed Delivery: 7-14 days DHL/FedEx to USA, DDP terms.
• Cost Savings: 30% below market via direct chain.
• Compliance: cGMP, ISO 9001, export to 50+ countries.

Dirlotapide Technical Specifications Table

diammonium edta dinutuximab gatipotuzumab

Real-World Applications & Case Studies

Case Study 1: USA vet pharma firm scaled from 5kg to 100kg dirlotapide, achieving 18% weight loss in trials—delivery in 10 days, 35% cost cut.

Case Study 2: OEM liquid formulation for export; zero batch failures, FDA submission success.

Request Custom Quote Today

Proven Trust: Factory, Clients, Testimonials

Customer Logo Wall: Served Zoetis partners, Merck Animal Health, US labs (confidential).

Certificates: GMP, DMF, FDA-registered, ISO 9001, RoHS. Full list on request.

FAQ: Dirlotapide Procurement Essentials

Real Customer Praise for Our Dirlotapide

"Best dirlotapide supplier ever! 99.6% pure, arrived in 9 days. Saved us $15k on first order."
- Mike T., Supply Chain Mgr, VetLab USA

"OEM service flawless. High-quality dirlotapide powder powered our new dog obesity line."
- Sarah L., Ops Director, PetHealth Inc.

"From inquiry to delivery: seamless. Quality beats competitors hands down."
- James K., Purchasing Lead, BioVet Solutions

"Free sample sealed the deal. Now regular buyer—fast, affordable, reliable."
- Lisa M., Tech Director, AnimalPharm USA

Secure Your Dirlotapide API Supply Today – Limited Stock!

Limited-time: Free 5g sample + 10% off first order. Money-back guarantee. Ships in 24h.

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan, China | Privacy Policy

Dr. Alex Chen

Senior Pharmaceutical Chemist at Global Technology Co., Ltd with 25+ years in API production. PhD from Peking University, authored 15+ papers on veterinary APIs. Oversees our dirlotapide line for global compliance.